Quantification of Urinary Phenyl-γ-Valerolactones and Related Valeric Acids in Human Urine on Consumption of Apples.
Andrea AnesiPedro MenaAchim BubMarynka UlaszewskaDaniele Del RioSabine E KullingFulvio MattiviPublished in: Metabolites (2019)
Flavan-3-ols are dietary bioactive molecules that have beneficial effects on human health and reduce the risk of various diseases. Monomeric flavan-3-ols are rapidly absorbed in the small intestine and released in the blood stream as phase II conjugates. Polymeric flavan-3-ols are extensively metabolized by colonic gut microbiota into phenyl-γ-valerolactones and their related phenylvaleric acids. These molecules are the main circulating metabolites in humans after the ingestion of flavan-3-ol rich-products; nevertheless, they have received less attention and their role is not understood yet. Here, we describe the quantification of 8 phenyl-γ-valerolactones and 3 phenylvaleric acids in the urine of 11 subjects on consumption of apples by using UHPLC-ESI-Triple Quad-MS with pure reference compounds. Phenyl-γ-valerolactones, mainly as sulfate and glucuronic acid conjugates, reached maximum excretion between 6 and 12 after apple consumption, with a decline thereafter. Significant differences were detected in the cumulative excretion rates within subjects and in the ratio of dihydroxyphenyl-γ-valerolactone sulfate to glucuronide conjugates. This work observed for the first time the presence of two distinct metabotypes with regards to the excretion of phenyl-γ-valerolactone phase II conjugates.
Keyphrases
- phase ii
- ms ms
- clinical trial
- open label
- human health
- cancer therapy
- risk assessment
- placebo controlled
- phase iii
- drug delivery
- double blind
- mass spectrometry
- multidrug resistant
- randomized controlled trial
- induced pluripotent stem cells
- drug induced
- liquid chromatography
- high resolution mass spectrometry
- gas chromatography
- tandem mass spectrometry